About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Airway Management in Temporomandibular Joint Ankylosis
Yasemin Burcu Ustun1, Cengiz Kaya1,  Yunus Oktay Atalay2, Ersin Koksal1, Ender Cam1
From the 1Department of Anesthesiology and Reanimation and 2Department of Radiology, Outpatient Anesthesia Service; Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey.   
Corresponding Author:
Dr. Yasemin Burcu Ustun
Email: burcu.ustun@omu.edu.tr 
Received: 21-AUG-2014 Accepted: 06-OCT-2014 Published Online: 05-NOV-2014
DOI: http://dx.doi.org/10.17659/01.2014.0108
Abstract
Temporomandibular joint (TMJ) ankylosis is an important functional pathology that restricts mouth-opening, decreases quality of life, and is associated with facial deformities and orthognathic and orthodontic problems. Airway management in such cases poses a multitude of challenges. This case report pertains to successful airway management in the background of difficult airway.
Keywords : Ankylosis, Temporomandibular Joint, Airway Management, Temporomandibular Joint Disorders, Mouth, Humans
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Jan 19, 2025